The mammalian target of rapamycin (mTOR) is a central growth controller. Recent studies have elucidated a conserved signaling pathway consisting of TSC1/TSC2-Rheb-mTOR. TSC1 and TSC2 are two tumor suppressor genes mutated in the tuberous sclerosis. The TSC1/TSC2 complex functions as a GTPase activating protein (GAP) to inhibit the Rheb small GTPase, which is a potent activator of mTOR. This signaling pathway integrates a wide range of extracellular and intracellular signals to regulate cell growth. mTOR activity is rapidly and dramatically regulated by the availability of cellular energy and amino acids. Previous studies have established that the TSC-mTOR pathway plays a critical role in the coordination between cell growth and nutrient availability at the cellular level. The major focus of this proposal is to investigate the function of TSC- Rheb-mTOR pathway in organismal energy balance and to elucidate the mechanism of this pathway in regulation of leptin signaling, appetite control, and energy expenditure. We will use mouse genetics and cell biological techniques to achieve these goals.
The specific aims for this proposal are:
Aim 1. To determine the function of TSC1 in POMC neurons in appetite and metabolic control and obesity Aim 2. To determine the function of TSC1 in AGRP/NPY neurons in regulation of appetite Aim 3. To elucidate the mechanism of mTOR activation in inducing leptin resistance and hyperphagia Aim 4. To determine the effect of low mTOR activity on food intake, metabolism, obesity, leptin sensitivity, and resistant to high fat diet-induced obesity.
The TSC-mTOR pathway plays a major role in hormonal and nutritional signals to regulate cell growth. This proposal will investigate the function of TSC-mTOR in affecting leptin signaling and appetite control. The information generated from this project will provide new insights into to appetite regulation, obesity, and diabetes.
|Yang, Hui; Lin, Huaipeng; Xu, Haiyan et al. (2014) TET-catalyzed 5-methylcytosine hydroxylation is dynamically regulated by metabolites. Cell Res 24:1017-20|
|Wang, Yi-Ping; Zhou, Li-Sha; Zhao, Yu-Zheng et al. (2014) Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress. EMBO J 33:1304-20|
|Jewell, Jenna L; Russell, Ryan C; Guan, Kun-Liang (2013) Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 14:133-9|
|Yuan, Hai-Xin; Xiong, Yue; Guan, Kun-Liang (2013) Nutrient sensing, metabolism, and cell growth control. Mol Cell 49:379-87|
|Ye, Dan; Ma, Shenghong; Xiong, Yue et al. (2013) R-2-hydroxyglutarate as the key effector of IDH mutations promoting oncogenesis. Cancer Cell 23:274-6|
|Zhao, Di; Zou, Shao-Wu; Liu, Ying et al. (2013) Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell 23:464-76|
|Kim, Joungmok; Guan, Kun-Liang (2013) AMPK connects energy stress to PIK3C3/VPS34 regulation. Autophagy 9:1110-1|
|Li, Li; Guan, Kun-Liang (2013) Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) is a negative regulator of the mammalian target of rapamycin complex 1 (mTORC1). J Biol Chem 288:703-8|
|Russell, Ryan C; Tian, Ye; Yuan, Haixin et al. (2013) ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 15:741-50|
|Kim, Joungmok; Kim, Young Chul; Fang, Chong et al. (2013) Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152:290-303|
Showing the most recent 10 out of 27 publications